Guardian Pharmacy Services (GRDN) Gains from Investment Securities (2023 - 2026)

Guardian Pharmacy Services has disclosed Gains from Investment Securities across 4 years of filings, most recently posting $79000.0 for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $79000.0, down 93.02% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 188.35% YoY), and the FY2025 annual result was -$1.1 million, down 40.16% from the prior year.
• Gains from Investment Securities came in at $79000.0 for Q1 2026 at Guardian Pharmacy Services, up from -$490000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.1 million in Q1 2025 to a low of -$4.1 million in Q4 2024.
• The 4-year median for Gains from Investment Securities is $440500.0 (2023), against an average of -$96100.0.
• Across the five-year window, Gains from Investment Securities sank 608.23% in 2024 and jumped 87.98% in 2025, its largest moves.
• Guardian Pharmacy Services' Gains from Investment Securities stood at $802000.0 in 2023, then tumbled by 608.23% to -$4.1 million in 2024, then soared by 87.98% to -$490000.0 in 2025, then soared by 116.12% to $79000.0 in 2026.
• The last three Gains from Investment Securities figures came in at $79000.0 (Q1 2026), -$490000.0 (Q4 2025), and -$155000.0 (Q3 2025), per Business Quant data.